A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
Study sponsor: BioVie Inc. · BIVI
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-09-30Actual
Enrollment · participants439Actual
Source updated2023-11-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.